Cargando…
Targeted therapy for hepatocellular carcinoma
The last 3 years have seen the emergence of promising targeted therapies for the treatment of hepatocellular carcinoma (HCC). Sorafenib has been the mainstay of treatment for a decade and newer modalities were ineffective and did not confer any increased therapeutic benefit until the introduction of...
Autores principales: | Huang, Ao, Yang, Xin-Rong, Chung, Wen-Yuan, Dennison, Ashley R., Zhou, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419547/ https://www.ncbi.nlm.nih.gov/pubmed/32782275 http://dx.doi.org/10.1038/s41392-020-00264-x |
Ejemplares similares
-
Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma
por: Ao, Huang, et al.
Publicado: (2021) -
The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis
por: Chen, Xu-Xiao, et al.
Publicado: (2017) -
Targeted Therapies in the Treatment of Advanced Hepatocellular Carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2013) -
Combination treatment including targeted therapy for advanced hepatocellular carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2016) -
Targeted Therapy in Hepatocellular Carcinoma
por: Chua, Clarinda W. L., et al.
Publicado: (2011)